ngµç×ÓÓÎÏ·

03
Ê×Ò³ / ½Ìѧ¿ÆÑÐ / ÕýÎÄ

ngµç×ÓÓÎÏ·ÖÐɽҽѧԺ/Á¥ÊôµÚÈýÒ½Ôº¡¢¡¢¡¢¸ßÖÝÊÐÈËÃñÒ½ÔºÁªºÏÍŶӷ¢Ã÷ÐÄÍâĤ֬·¾-½»¸ÐÏ໥×÷ÓÃÓÕ·¢ÐÄÂÉʧ³£µÄлúÖÆ

¸å¼þȪԴ£º£º £ºÖÐɽҽѧԺ ±à¼­£º£º £ºÌ¸Ï£¡£¡¢¡¢¡¢Â¬ì½Î¬ ÉóºË£º£º £ºËïÒ«±ó ÔĶÁÁ¿£º£º £º

ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±ÕÅÓñçù£©ÐÄÂÉʧ³££¨Arrhythmia£©Ó°Ïì×ÅÈ«ÇòÁè¼Ý1200ÍòÈË£¬ÇÒ·¢²¡ÂÊÒ²ÔÚÒ»Ö±ÉÏÉý£¬ÊÇÐÄÔ´ÐÔâ§ËÀµÄÖ÷ÒªÔ­ÒòÖ®Ò»¡£ÐÄÂÉʧ³£ÓÕ·¢ÒòËØÖڶ࣬Ñо¿Åú×¢½»¸ÐÉñ¾­ÏµÍ³£¨Sympathetic nervous system, SNS£©»î¶¯Òì³£º£º £ºÍÐÄÍâĤ֬·¾(Epicardial adipose tissue, EAT)ÔöºñÊÇÐÄÂÉʧ³£±¬·¢µÄÖ÷ÒªµÄ×ÔÁ¦·çÏÕÒòËØ¡£ÐÄÍâĤ֬·¾°üÈÆ×Ŵ󲿷ÖÐÄÔཻ¸ÐÉñ¾­£¬Á½ÕßÌØÊâµÄλÖùØÏµÌáÐÑÐÄÍâĤ֬·¾ºÍÐĽ»¸ÐÉñ¾­Ö®¼äµÄÏ໥×÷ÓÿÉÄÜÔÚÐÄÂÉʧ³£±¬·¢ÖÐÊÎÑÝÖ÷ÒªµÄ½ÇÉ«¡£È»¶ø£¬ÓÉÓÚÎïÖÖ²î±ðºÍÂ×ÀíÏÞÖÆ£¬ÏÖÔÚÉÐÎÞÖ±½ÓÖ¤¾Ý֤ʵ֬·¾-½»¸ÐÉñ¾­Ï໥×÷ÓüÓÈëÐÄÂÉʧ³£µÄ±¬·¢¡£

¿ËÈÕ£¬ngµç×ÓÓÎÏ·ÖÐɽҽѧԺÀîΰǿ½ÌÊÚ¡¢¡¢¡¢ÏîÅô½ÌÊÚÍŶÓ¡¢¡¢¡¢ngµç×ÓÓÎÏ·Á¥ÊôµÚÈýÒ½ÔºÖì½àÃ÷½ÌÊÚÍŶӺ͸ßÖÝÊÐÈËÃñÒ½ÔºÖìÐãÁú½ÌÊÚÍŶÓÏàÖúÔÚCell Reports MedicineÔÓÖ¾ÉϽÒÏþÌâΪ¡°The adipose-neural axis is involved in epicardial adipose tissue-related cardiac arrhythmias¡±µÄÎÄÕ£¬ÀÖ³ÉÕ¹ÏÖÁËÐÄÍâĤ֬·¾-ÐĽ»¸ÐÉñ¾­ÔÚÐÄÂÉʧ³£ÖеÄÖ÷Òª×÷Óò¢ÆÊÎöÁËÆä×÷ÓûúÖÆ¡£

¸ÃÑо¿Ê¹ÓøÉϸ°ûȪԴµÄÐļ¡Ï¸°û¡¢¡¢¡¢½»¸ÐÉñ¾­ÔªºÍÖ¬·¾Ï¸°û½¨ÉèÁ˽»¸Ð-Ðļ¡¡¢¡¢¡¢Ö¬·¾ÉÏÇå-Ðļ¡¡¢¡¢¡¢Ö¬·¾ÉÏÇå-½»¸Ð-ÐÈÈýÖÖ²î±ðµÄ¹²×÷Óýϵͳ£¬¼ì²âÕâЩ¹²×÷ÓýÌõ¼þÏÂÐļ¡Ï¸°ûµÄ¸ÆË²±äÇéÐΣ¨¸ÆË²±äÊÇÓÉÐ˷ܼ¤¶¯ËùÓÕ·¢µÄÐļ¡Ï¸°û°ûÖÊÄÚ˲ʱÐÔ¸ÆÔö¸ß£¬ÊÇÐļ¡Ï¸°ûÖ÷ÒªµÄCa2+´¦ÀíÌØÕ÷£¬ÓëÐļ¡Ï¸°ûËõ¶Ì½ÚÂÉÇ×½üÏà¹Ø£©¡£Ð§¹û·¢Ã÷£¬Ðļ¡Ï¸°ûÓëÖ¬·¾ÉÏÇå»ò½»¸ÐÉñ¾­¹²×÷Óýʱ£¬Ðļ¡Ï¸°û±¬·¢¸ÆË²Òì³£µÄƵÂʽÏδ´¦ÀíµÄÐļ¡Ï¸°ûÎÞÏÔÖø¸Ä±ä £»È»¶ø£¬×÷ÓýϵͳÖÐͬʱ¼ÓÈëÖ¬·¾ÉÏÇåºÍ½»¸ÐÉñ¾­Ê±£¨¼´ÈýÕß¹²×÷Óý×飩£¬Ðļ¡Ï¸°û¸ÆË²±äÒì³£µÄ±¬·¢ÆµÂÊÏÔןßÓÚÆäËûÁ½Á½¹²×÷Óýϵͳ¡£Í¬Ê±£¬Î¢µç¼«ÕóÁмì²âЧ¹ûÏÔʾÈýÕß¹²×÷Óý×éÖУ¬Ðļ¡Ï¸°ûµç´«µ¼Ä£Ê½¸Ä±ä£¬±¬·¢ÀàËÆÐÄÂÉʧ³£Ñù¸Ä±ä¡£½øÒ»²½Ñо¿·¢Ã÷£¬Ö¬·¾Ï¸°ûÒò×Óleptinͨ¹ýleptinÊÜÌ弤»îSOCS3½ø¶øÒÖÖÆJAK2/SATA3ͨ·£¬´Ùʹ½»¸ÐÉñ¾­ÉøÍ¸¸ü¸ßˮƽµÄÉñ¾­µÝÖÊ¡£Í¬Ê±£¬¸ÃÑо¿·¢Ã÷£¬½»¸ÐÉñ¾­Ö÷ÒªÒÀÀµÓÚÉñ¾­ëÄY£¨NPY£©ÓëY1RµÄÏ໥×÷Óõ¼ÖÂÐļ¡Ï¸°ûµÄ½ÚÂÉÒì³£¡£ ÁÙ´²Êý¾Ý½øÒ»²½Åú×¢£¬ÐÄÍâĤ֬·¾ÔöºñµÄ·¿²ü»¼Õ߯ä¹Ú×´ñ¼ÑªÇåÖÐNPYµÄº¬Á¿Ô¶¸ßÓÚ·ÇÐÄÍâĤ֬·¾ÔöºñµÄ·¿²ü»¼Õߣ¬ÇÒÓë·¿²üµÄÑÏÖØ³Ì¶È³ÊÕýÏà¹Ø¡£

×îºó£¬Ñо¿Ö°Ô±Ì½ÌÖÁËNPYÓÕ·¢Ðļ¡Ï¸°û½ÚÂÉÒì³£µÄ·Ö×Ó»úÖÆ£¬·¢Ã÷ÈýÕß¹²×÷Óý×éµÄÐļ¡Ï¸°ûÄÚ¸Æ/¸Æµ÷ÂѰ×ÒÀÀµÐÔÂѰ׼¤Ã¸ II £¨CaMK¢ò£©¡¢¡¢¡¢ÄƸƽ»Á÷Ì壨NCX£©»îÐÔÉý¸ß£¬µ¼ÖÂÑÓ³Ùºó³ý¼«£¨DADs£©ÔöÌí£¬ÒýÆðÐļ¡Ï¸°û¸ÆË²±äÒì³££¬±¬·¢ÐÄÂÉʧ³£Ñù¸Ä±ä¡£¶øY1ÊÜÌåÒÖÖÆ¼Á¡¢¡¢¡¢CaMK¢òÒÖÖÆ¼Á¡¢¡¢¡¢NCXÒÖÖÆ¼Á¿ÉÒÔÓÐÓÃ×è¶ÏNPYµÄÖÂÐÄÂÉʧ³£×÷Óá£

048F83850B7E9DA2B57F42D7421_B455315B_391EE

×ÛÉÏËùÊö£¬¸ÃÑо¿Í¨¹ý½¨Éè¹²×÷ÓýÄ£×ÓÄ£ÄâÐÄÔà×é֯΢ÇéÐΣ¬ÉîÈë̽ÌÖÐÄÍâĤ֬·¾ÏàÌåÌùÂÉʧ³£µÄ±¬·¢ÆøÀí¡£Ñо¿Ð§¹ûÅú×¢£¬Ö¬·¾Òò×Óleptin¼¤»î½»¸ÐÉñ¾­£¬´ÙʹÆäÉøÍ¸¸ü¸ßˮƽµÄNPY¡£NPYͨ¹ýY1RÊÜÌåÒýÆðÐļ¡Ï¸°ûÄÚ¸ÆÎÈ̬Òì³££¬ÓÕ·¢Ðļ¡Ï¸°ûÐÄÂÉʧ³£Ñù¸Ä±ä¡£ÒÖÖÆY1RºÍÏÂÓθÆÐźÅÏà¹ØÂѰ׿ÉÒÔÓÐÓÃ×è¶ÏNPYµÄ×÷Ó᣸ÃÑо¿Ö¤ÊµÖ¬·¾-Éñ¾­Öá¼ÓÈëÐÄÂÉʧ³£µÄ±¬·¢£¬ÎªÐÄÂÉʧ³£µÄÖÎÁÆÌṩÁËDZÔÚµÄае㡣ͬʱ£¬Ò²ÎªÑо¿EAT/ ½»¸ÐÉñ¾­ÏµÍ³Ïà¹Ø¼²²¡µÄ·¢²¡»úÖÆ¡¢¡¢¡¢Ì½Ë÷Ô¤·À/ÖÎÁÆÕ½ÂÔÌṩÓÐÁ¦µÄ¹¤¾ß¡£

ngµç×ÓÓÎÏ·ÖÐɽҽѧԺµÄÀîΰǿ½ÌÊÚ¡¢¡¢¡¢ÏîÅô½ÌÊÚ£¬ngµç×ÓÓÎÏ·Á¥ÊôµÚÈýÒ½ÔºÖì½àÃ÷½ÌÊں͸ßÖÝÊÐÈËÃñÒ½ÔºÖìÐãÁú½ÌÊÚΪÅäºÏͨѶ×÷Õß £»ÍŶӳÉÔ±·¶Óñ±¦²©Ê¿¡¢¡¢¡¢»ÆÉºÉº²©Ê¿ºÍÀîËÕ»ª¸±Ö÷ÈÎҽʦΪÅäºÏµÚÒ»×÷Õß¡£

ÂÛÎÄÁ´½Ó£º£º £ºhttps://doi.org/10.1016/j.xcrm.2024.101559

¡¾ÍøÕ¾µØÍ¼¡¿